Clinical trial · Observational
EUS Glue vs Endoscopic Variceal Band Ligation for Prevention of Rebleeding in Patients With HCC and EV Bleeding: a Retrospective Comparative Study
EUS Guided Cyanoacrylate Injection vs Endoscopic Variceal Band Ligation for Prevention of Rebleeding in Patients With Hepatocellular Carcinoma and Esophageal Variceal Bleeding: a Retrospective Comparative Study
NCT04918459CI-TRIAL-00106026EUSgluevsVBLactive not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
SP by EUS-CYA improves clinical outcomes (eg, EV rebleeding) in patients with HCC and prior EV bleeding when compared with SP by EGD-VBL
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endoscopic Variceal Band Ligation | — | UNRESOLVED | — |
| Esophageal Variceal Bleeding | — | UNRESOLVED | — |
| EUS Guided Cyanoacrylate Injection | — | UNRESOLVED | — |
| Hepatocelular Carcinoma | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- EUS guided cyanoacrylate injection
- description
- EUS guided cyanoacrylate injection to prevent EV rebleeding.
- label
- variceal band ligation
- description
- variceal band ligation to prevent EV rebleeding.
Primary outcomes (1)
- measure
- Death adjusted cumulative incidence of rebleeding at 30-day
- timeFrame
- 30 days
- description
- Death adjusted cumulative incidence of rebleeding at 30-day
Secondary outcomes (4)
- measure
- Death adjusted cumulative incidence of rebleeding at 90-day
- timeFrame
- 90 days
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Consecutive HCC patients with history of EV bleeding who underwent EUS guided cyanoacrylate injection or variceal band ligation by EGD for secondary prophylaxis to prevent EV rebleeding 2. Age \> 18 years Exclusion Criteria: 1. HCC patients with non-variceal upper GI bleeding 2. HCC patients with history of EV bleeding who did not undergo further endoscopy for secondary prophylaxis for EV rebleeding
References
Publications (0)
Data not yet available
No reference posted for this study.